We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Napo Pharm.Regs | NAPL | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.35 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.35 | 0.35 |
| Top Posts |
|---|
Posted at 09/5/2008 10:19 by monis More info. What is interesting is that it was only in March of this year that they announced the following....The Company is also raising approximately $0.3 million by issuing 600,000 common shares by way of the Subscription at 25 pence, which represents a 7.4 per cent discount to the closing mid-price of the common shares on 5 March 2008. You would presume that the investor must be confident of a commercial partner for Napo and CRO-HIV. All the indications since are that the results have been underestimated. The more I research the company the more immediate upside to it I see. Still ridiculously cheap imho. DYOR. |
Posted at 26/4/2008 16:49 by monis double - Only last month 600,000 shares were bought by an investor from the company at 25p. It only bodes well,I think this is just being walked back up in anticipation of a partnership agreement. DYOR |
Posted at 24/4/2008 18:27 by monis Extract from prelimary results earlier this month....In March 2008, the Company issued 600,000 shares of common stock to an investor at 25 pence per share. He/she must know roughly what the short term future is as that was only a month ago. Looking good for the morning. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
